2018 Select Poster Presentations

Presentation Description: 
This session featured oral presentations of select posters on display at the 2018 Symposium.
Click on the abstract title to view the combined abstract and poster.

Poster presenters:

Novel Genetic Markers and Drug Exposure as Predictors of Thiopurine Sensitivity in Childhood Acute Lymphoblastic Leukemia
Alexandra Zorzi, MD, FRCPC, Children’s Hospital, London Health Sciences Centre

A Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency from Non-Neoplastic Tissue
Andrew Shuen, PhD Candidate, MD, FRCPC, The Hospital for Sick Children

A Needs Assessment Focused on Home-Based Care for Children with Cancer: A Qualitative Descriptive Study using the Perspectives of Children, Parents, and Healthcare Providers
Lauren Mulrooney, Nursing Student (3rd year), University of Ottawa

Predictive Modelling of Cancer Type in Li-Fraumeni Syndrome
Valli Subasri, MSc candidate (Medical Biophysics), University of Toronto

Measuring Quality in a Childhood Cancer System: An Updated Environmental Scan ff Existing Quality Indicators
Nicole Espinosa, BScH Candidate (Life Sciences), Queens University

Validating a Questionnaire to Assess the use of Complementary Health Approaches Among Children with Cancer and their Parents: A Systematic Review of Questionnaires Assessing Cha use in Pediatrics
Mohammad R. Alqudimat, PhD Student (Nursing), University of Toronto

Exploring the Perception and Impact of Survivor Care Plans in the Aftercare Program: A Qualitative Study
Marta Wilejto, Assistant Professor Paediatric Hematology/Oncology, Children’s Hospital, London Health Sciences Centre

Abstract: *
POGO Patient and Family Education Roadmap Project
Sarah Naraine, Fourth Year Nursing Student, Ryerson University
*Due to animations on the slide the PDF has been embedded with video format (will played when downloaded)

Abstract: *
Parent-Child Communication when a Child has Cancer
Ceilidh Eaton Russell, PhD, University of Guelph

Economic Evaluation of Chimeric Antigen Receptor T-Cells (Car T-Cell) Therapy for High-Risk Relapsed Acute Lymphoblastic Leukemia in Children
Jill Furzer, PhD candidate (health economics), University of Toronto; Hospital for Sick Children

Comments are closed.